Zeiss and Bruker Combine Technologies for Nontargeted Molecular Histology
Carl Zeiss will integrate its MIRAX Virtual Slide Scanner into Bruker Daltonics’ MALDI Molecular Imager™. In the past, a major bottleneck in pathology research has been the interpretation of MALDI imaging results in a histological context. Combining the two technologies, the companies report, allows the direct overlay of the full microscopic image with the entire molecular and spectral information in one visualization software tool, enabling untargeted molecular histology.
The MALDI Molecular Imager allows histology researchers to measure spatially resolved peptide, protein, and lipid profiles in tissue sections. Zeiss Mirax Scanner is scalable online and has a high-lateral resolution that can zoom in to any tissue sections investigated by MALDI.